Noncytotoxic inhibition of cytomegalovirus replication through NK cell protease granzyme m-mediated cleavage of viral phosphoprotein 71

Journal of Immunology

Volumn 185, Issue 12, 2010, Pages 7605-7613

  Van Domselaar, Robert ^a   Philippen, Leonne E ^a   Quadir, Razi ^a   Wiertz, Emmanuel J H J ^b   Kummer, J Alain ^a,c   Bovenschen, Niels ^a  

^a Department of Pathology ^*  (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CELL PROTEIN; GRANZYME M; IMMEDIATE EARLY PROTEIN; PHOSPHOPROTEIN 71; STREPTOLYSIN O; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL DEATH; CELLULAR DISTRIBUTION; CLINICAL EVALUATION; CYTOMEGALOVIRUS INFECTION; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; INFECTION PREVENTION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; VIRUS REPLICATION;

ANIMALS; BACTERIAL PROTEINS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GRANZYMES; HELA CELLS; HUMANS; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; MICE; MICE, KNOCKOUT; STREPTOLYSINS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 78650639499     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001503     Document Type: Article

References (56)

1. Mocarski, E. S., T. Shenk, and R. F. Pass. 2007. Cytomegaloviruses. In Fields Virology, 5th Ed.., P. M. Knipe, D. E. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus, eds. Lippincott Williams & Wilkins, Philadelphia, PA, p. 2701-2772.
2. Crough, T., and R. Khanna. 2009. Immunobiology of human cytomegalovirus: from bench to bedside. Clin. Microbiol. Rev. 22:76-98.
3. Chee, M. S., A. T. Bankier, S. Beck, R. Bohni, C. M. Brown, R. Cerny, T. Horsnell, C. A. Hutchison, III, T. Kouzarides, J. A. Martignetti, et al. 1990. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154:125-169.
4. Davison, A. J., A. Dolan, P. Akter, C. Addison, D. J. Dargan, D. J. Alcendor, D. J. McGeoch, and G. S. Hayward. 2003. The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. J. Gen. Virol. 84:17-28.
5. Dunn, W., C. Chou, H. Li, R. Hai, D. Patterson, V. Stolc, H. Zhu, and F. Liu. 2003. Functional profiling of a human cytomegalovirus genome. Proc. Natl. Acad. Sci. USA 100:14223-14228.
6. Chen, D. H., H. Jiang, M. Lee, F. Liu, and Z. H. Zhou. 1999. Three-dimensional visualization of tegument/capsid interactions in the intact human cytomegalovirus. Virology 260:10-16.
7. Britt, W. J., and S. Boppana. 2004. Human cytomegalovirus virion proteins. Hum. Immunol. 65:395-402.
8. Kalejta, R. F. 2008. Tegument proteins of human cytomegalovirus. Microbiol. Mol. Biol. Rev. 72:249-265.
9. Abate, D. A., S. Watanabe, and E. S. Mocarski. 2004. Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J. Virol. 78:10995-11006.
10. Baldick, C. J., Jr., A. Marchini, C. E. Patterson, and T. Shenk. 1997. Human cytomegalovirus tegument protein pp71 (ppUL82) enhances the infectivity of viral DNA and accelerates the infectious cycle. J. Virol. 71:4400-4408.
11. Bresnahan, W. A., and T. E. Shenk. 2000. UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells. Proc. Natl. Acad. Sci. USA 97:14506-14511.
12. Browne, E. P., and T. Shenk. 2003. Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells. Proc. Natl. Acad. Sci. USA 100:11439-11444.
13. Liu, B., and M. F. Stinski. 1992. Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J. Virol. 66:4434-4444.
14. Barry, M., and R. C. Bleackley. 2002. Cytotoxic T lymphocytes: all roads lead to death. Nat. Rev. Immunol. 2:401-409.
15. Chowdhury, D., and J. Lieberman. 2008. Death by a thousand cuts: granzyme pathways of programmed cell death. Annu. Rev. Immunol. 26:389-420.
16. Loh, J., D. T. Chu, A. K. O'Guin, W. M. Yokoyama, and H. W. Virgin, IV. 2005. Natural killer cells utilize both perforin and g interferon to regulate murine cytomegalovirus infection in the spleen and liver. J. Virol. 79:661-667.
17. + T cells: diversity specialists. Immunol. Rev. 211:225-235.
18. Sayers, T. J., A. D. Brooks, J. M. Ward, T. Hoshino, W. E. Bere, G. W. Wiegand, J. M. Kelly, and M. J. Smyth. 2001. The restricted expression of granzyme M in human lymphocytes. J. Immunol. 166:765-771.
19. de Koning, P. J., K. Tesselaar, N. Bovenschen, S. Colak, R. Quadir, T. J. Volman, and J. A. Kummer. 2010. The cytotoxic protease granzyme M is expressed by lymphocytes of both the innate and adaptive immune system. Mol. Immunol. 47:903-911.
20. Hua, G., Q. Zhang, and Z. Fan. 2007. Heat shock protein 75 (TRAP1) antagonizes reactive oxygen species generation and protects cells from granzyme M-mediated apoptosis. J. Biol. Chem. 282:20553-20560.
21. Kelly, J. M., N. J. Waterhouse, E. Cretney, K. A. Browne, S. Ellis, J. A. Trapani, and M. J. Smyth. 2004. Granzyme M mediates a novel form of perforindependent cell death. J. Biol. Chem. 279:22236-22242.
22. de Koning, P. J., J. A. Kummer, and N. Bovenschen. 2009. Biology of granzyme M: a serine protease with unique features. Crit. Rev. Immunol. 29:307-315.
23. Bovenschen, N., P. J. de Koning, R. Quadir, R. Broekhuizen, J. M. Damen, C. J. Froelich, M. Slijper, and J. A. Kummer. 2008. NK cell protease granzyme M targets a-tubulin and disorganizes the microtubule network. J. Immunol. 180:8184-8191.
24. Cullen, S. P., I. S. Afonina, R. Donadini, A. U. Lüthi, J. P. Medema, P. I. Bird, and S. J. Martin. 2009. Nucleophosmin is cleaved and inactivated by the cytotoxic granule protease granzyme M during natural killer cell-mediated killing. J. Biol. Chem. 284:5137-5147.
25. Pao, L. I., N. Sumaria, J. M. Kelly, S. van Dommelen, E. Cretney, M. E. Wallace, D. A. Anthony, A. P. Uldrich, D. I. Godfrey, J. M. Papadimitriou, et al. 2005. Functional analysis of granzyme M and its role in immunity to infection. J. Immunol. 175:3235-3243.
26. Skaletskaya, A., L. M. Bartle, T. Chittenden, A. L. McCormick, E. S. Mocarski, and V. S. Goldmacher. 2001. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc. Natl. Acad. Sci. USA 98:7829-7834.
27. Goldmacher, V. S., L. M. Bartle, A. Skaletskaya, C. A. Dionne, N. L. Kedersha, C. A. Vater, J. W. Han, R. J. Lutz, S. Watanabe, E. D. Cahir McFarland, et al. 1999. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc. Natl. Acad. Sci. USA 96:12536-12541.
28. Terhune, S., E. Torigoi, N. Moorman, M. Silva, Z. Qian, T. Shenk, and D. Yu. 2007. Human cytomegalovirus UL38 protein blocks apoptosis. J. Virol. 81:3109-3123.
29. Reeves, M. B., A. A. Davies, B. P. McSharry, G. W. Wilkinson, and J. H. Sinclair. 2007. Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death. Science 316:1345-1348.
30. + T cell inhibition of HSV-1 reactivation from neuronal latency. Science 322:268-271.
31. Andrade, F., E. Fellows, D. E. Jenne, A. Rosen, and C. S. Young. 2007. Granzyme H destroys the function of critical adenoviral proteins required for viral DNA replication and granzyme B inhibition. EMBO J. 26:2148-2157.
32. Kalejta, R. F., J. T. Bechtel, and T. Shenk. 2003. Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors. Mol. Cell. Biol. 23:1885-1895.
33. Alban, A., S. O. David, L. Bjorkesten, C. Andersson, E. Sloge, S. Lewis, and I. Currie. 2003. A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3:36-44.
34. Shen, W., E. Westgard, L. Huang, M. D. Ward, J. L. Osborn, N. H. Chau, L. Collins, B. Marcum, M. A. Koach, J. Bibbs, et al. 2008. Nuclear trafficking of the human cytomegalovirus pp71 (ppUL82) tegument protein. Virology 376:42-52.
35. Mahrus, S., and C. S. Craik. 2005. Selective chemical functional probes of granzymes A and B reveal granzyme B is a major effector of natural killer cellmediated lysis of target cells. Chem. Biol. 12:567-577.
36. Rukamp, B. J., C. M. Kam, S. Natarajan, B. W. Bolton, M. J. Smyth, J. M. Kelly, and J. C. Powers. 2004. Subsite specificities of granzyme M: a study of inhibitors and newly synthesized thiobenzyl ester substrates. Arch. Biochem. Biophys. 422:9-22.
37. Mahrus, S., W. Kisiel, and C. S. Craik. 2004. Granzyme M is a regulatory protease that inactivates proteinase inhibitor 9, an endogenous inhibitor of granzyme B. J. Biol. Chem. 279:54275-54282.
38. Hofmann, H., H. Sindre, and T. Stamminger. 2002. Functional interaction between the pp71 protein of human cytomegalovirus and the PML-interacting protein human Daxx. J. Virol. 76:5769-5783.
39. Chau, N. H., C. D. Vanson, and J. A. Kerry. 1999. Transcriptional regulation of the human cytomegalovirus US11 early gene. J. Virol. 73:863-870.
40. Homer, E. G., A. Rinaldi, M. J. Nicholl, and C. M. Preston. 1999. Activation of herpesvirus gene expression by the human cytomegalovirus protein pp71. J. Virol. 73:8512-8518.
41. Hwang, J., and R. F. Kalejta. 2007. Proteasome-dependent, ubiquitinindependent degradation of Daxx by the viral pp71 protein in human cytomegalovirus-infected cells. Virology 367:334-338.
42. Preston, C. M., and M. J. Nicholl. 2006. Role of the cellular protein hDaxx in human cytomegalovirus immediate-early gene expression. J. Gen. Virol. 87:1113-1121.
43. Cantrell, S. R., and W. A. Bresnahan. 2006. Human cytomegalovirus (HCMV) UL82 gene product (pp71) relieves hDaxx-mediated repression of HCMV replication. J. Virol. 80:6188-6191.
44. Saffert, R. T., and R. F. Kalejta. 2006. Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J. Virol. 80:3863-3871.
45. Woodhall, D. L., I. J. Groves, M. B. Reeves, G. Wilkinson, and J. H. Sinclair. 2006. Human Daxx-mediated repression of human cytomegalovirus gene expression correlates with a repressive chromatin structure around the major immediate early promoter. J. Biol. Chem. 281:37652-37660.
46. Döhner, K., C. H. Nagel, and B. Sodeik. 2005. Viral stop-and-go along microtubules: taking a ride with dynein and kinesins. Trends Microbiol. 13:320-327.
47. Mai, R. T., T. S. Yeh, C. F. Kao, S. K. Sun, H. H. Huang, and Y. H. Wu Lee. 2006. Hepatitis C virus core protein recruits nucleolar phosphoprotein B23 and coactivator p300 to relieve the repression effect of transcriptional factor YY1 on B23 gene expression. Oncogene 25:448-462.
48. Huang, W. H., B. Y. Yung, W. J. Syu, and Y. H. Lee. 2001. The nucleolar phosphoprotein B23 interacts with hepatitis d antigens and modulates the hepatitis d virus RNA replication. J. Biol. Chem. 276:25166-25175.
49. Hensel, G. M., H. H. Meyer, I. Buchmann, D. Pommerehne, S. Schmolke, B. Plachter, K. Radsak, and H. F. Kern. 1996. Intracellular localization and expression of the human cytomegalovirus matrix phosphoprotein pp71 (ppUL82): evidence for its translocation into the nucleus. J. Gen. Virol. 77:3087-3097.
50. Saffert, R. T., and R. F. Kalejta. 2007. Human cytomegalovirus gene expression is silenced by Daxx-mediated intrinsic immune defense in model latent infections established in vitro. J. Virol. 81:9109-9120.
51. Bego, M., J. Maciejewski, S. Khaiboullina, G. Pari, and S. St Jeor. 2005. Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus. J. Virol. 79:11022-11034.
52. Penkert, R. R., and R. F. Kalejta. 2010. Nuclear localization of tegumentdelivered pp71 in human cytomegalovirus-infected cells is facilitated by one or more factors present in terminally differentiated fibroblasts. J. Virol. 84:9853-9863.
53. Reeves, M. B., and J. H. Sinclair. 2010. Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter. J. Gen. Virol. 91:599-604.
54. + T-cell differentiation in response to viruses. Nat. Rev. Immunol. 3:931-939.
55. Reeves, M. B., P. J. Lehner, J. G. Sissons, and J. H. Sinclair. 2005. An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling. J. Gen. Virol. 86:2949-2954.
56. + cells. J. Virol. 84:5594-5604.